News
Investors may get a second bite at the apple, and a second chance to buy this GLP-1 drug leader at a discount price.
"The Novo Nordisk Foundation is increasing its influence and has appointed its chairman, Lars Rebien Sørensen, as an observer ...
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...
Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback